SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-015182
Filing Date
2023-06-09
Accepted
2023-06-09 16:15:24
Documents
2
Period of Report
2023-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4080
2 EX-24 DOCUMENT attachment1.htm EX-24 3811
  Complete submission text file 0000899243-23-015182.txt   9320
Mailing Address BROOKSIDE CAPITAL MANAGEMENT LLC JOHN HANCOCK TOWER, 200 CLARENDON STREET BOSTON MA 02116
Business Address
FERRANTE DOMENIC J (Reporting) CIK: 0001213397 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40227 | Film No.: 231005451

Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 617-229-6499
Finch Therapeutics Group, Inc. (Issuer) CIK: 0001733257 (see all company filings)

IRS No.: 823433558 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)